Macro-Aspartate Aminotransferase and Its Laboratory Detection: A Case Report
Goda Aleknavičiūtė-Valienė1, Linas Černiauskas2, Mantas Riauka3
1Center of Laboratory Medicine, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania.
Acta Medica Lituanica
|March 22, 2024
Summary
Elevated liver enzymes like AST can indicate disease, but may also be due to benign macro-enzymes. Identifying macro-AST avoids unnecessary invasive procedures and tests.
Area of Science:
- Clinical Chemistry
- Biochemistry
- Diagnostic Medicine
Background:
- Elevated enzyme activity in human blood serum often signals disease.
- Benign conditions, such as macro-enzymes, can also cause elevated enzyme levels.
- Macro-enzymes may lead to unnecessary invasive procedures, patient complications, and increased healthcare costs.
Observation:
- A 71-year-old asymptomatic female presented with persistently elevated aspartate aminotransferase (AST) levels.
- The patient was referred for further testing to investigate potential underlying liver disease.
- Diagnostic work-up included a polyethylene glycol (PEG) precipitation assay.
Findings:
- The polyethylene glycol (PEG) precipitation assay successfully identified macro-AST in the patient's serum.
- This diagnosis helped to avoid the need for a high-risk liver biopsy.
Implications:
- Physicians should consider diagnostic work-up for macro-AST in cases of isolated AST elevation without clinical signs of liver disease.
- Accurate diagnosis of macro-enzymes can prevent unnecessary, invasive, and costly medical interventions.
- Distinguishing between pathological and benign causes of enzyme elevation is crucial for appropriate patient management.
More Related Videos
11:03Use of Capillary Electrophoresis Immunoassay to Search for Potential Biomarkers of Amyotrophic Lateral Sclerosis in Human Platelets
Published on: February 10, 2020
7.3K
08:14Extraction of Non-Protein Amino Acids from Cyanobacteria for Liquid Chromatography-Tandem Mass Spectrometry Analysis
Published on: December 9, 2022
3.8K
